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Background: The treatment of uveal melanoma has seen a shift towards eye conserving treatments. Efforts have
been made towards the identification of patients at high risk of metastatic disease with the use of prognostic fine
needle biopsy, Monosomy 3 a risk factor for metastatic death thought to occur early in the development of uveal
melanoma.
Case presentation: We report a case in which an atypical optic nerve lesion was found to be a peripapillary primary
uveal melanoma with distinct non-pigmented and pigmented halves on gross dissection and corresponding disomy
3 and monosomy 3 halves. The tumour demonstrated rapid growth with apparent transformation from disomy 3 to
monosomy 3.
Conclusions: These are clinical features that challenge the current concepts of the cytogenetic pathogenesis of
uveal melanoma and demonstrate the potential problems and limitations of prognostic fine needle biopsy and
molecular classifications.
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The treatment of uveal melanoma has shifted towards
eye conserving treatments, prognostic fine needle biopsy
used to identify patients at risk of metastatic disease.
Monosomy 3 is associated with a high risk of progression
to metastatic death [1,2] and is thought to occur early in
the development of uveal melanoma [2-4]. More recently,
molecular classifications using gene expression profiling
have been used, dividing tumours into those with a low
metastatic potential (class I), those with a short term low
metastatic potential, but higher mid to long term risk
(class Ib) and those with short-term high metastatic
potential (class II) [5].
We report a case in which an atypical optic nerve lesion,
was found to be a peripapillary primary uveal melanoma
with distinct non-pigmented and pigmented halves on gross
dissection and corresponding disomy 3 and monosomy
3 halves. The tumour demonstrated rapid growth with
apparent transformation from disomy 3 to monosomy
3, clinical features that challenge the current concepts
of the cytogenetic pathogenesis of uveal melanoma and* Correspondence: limlianne@gmail.com
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reproduction in any medium, provided the ordemonstrate the potential problems and limitations of
prognostic fine needle biopsy and molecular classifications.
Case presentation
A 55- year- old man presented with a 4-year history of
progressively worsening visual acuity in his right eye. His
background medical history was otherwise unremarkable.
On examination, visual acuity was 20/20 in the left eye
and counting fingers at 1 m in the right eye. There was
a right relative afferent pupillary defect, and a right
central scotoma on fields to confrontation. Extraocular
movements and intraocular pressure was within normal
limits in both eyes and slit lamp examination was normal.
On dilated fundoscopic examination, there was diffuse
disc edema with marked disc hemorrhage and a related
serous retinal detachment, findings suggestive of an optic
nerve tumour (Figure 1a). Fluorescein angiography showed
a well-vascularized mass at the optic nerve head, with
fluorescein leak seen in late phase images. A provisional
diagnosis of an optic nerve meningioma was given and
the patient was referred for an MRI. MRI of the orbits
however, showed an elevated intraocular lesion at the
posterior pole with a moderately high signal on T1
weighted images suggestive of a peripapillary choroidal. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Clinical and pathological findings. (a) Initial dilated fundus examination: disc edema, hemorrhage and a serous retinal detachment.
(b) Fundus examination 10 months later: increase in the size of the mass, with disc border hemorrhage and an adjacent ring of pigmentation. (c) (d)
Gross pathology: uveal melanoma with distinct non-pigmented and pigmented halves. (e) Histopathological section of the non-pigmented half of the
uveal melanoma, spindle cell type. (f) Histopathological section of the pigmented half of the uveal melanoma, of spindle cell type with melanin.
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confirmed the presence of a dome shaped lesion 4.6 mm
in thickness as well as a retinal detachment (Figure 2b).
Standardized ultrasound with A-scan probe revealed a
solid lesion with low internal reflectivity and positive
kappa angle (Figure 2c). These findings confirmed the
diagnosis of choroidal melanoma. At that time, the patient
did not wish to proceed with further management and
was subsequently lost to follow up. He did however
represent 10 months later. The lesion appeared to have
rapidly increased in size, with further disc hemorrhage
at the temporal border from 7 to 11 o’clock and a ring
of adjacent retinal pigmentation (Figure 1b).
Enucleation was performed. Gross pathology revealed
a uveal melanoma arising in the area adjacent to the
optic nerve with distinct non-pigmented and pigmented
halves (Figure 1c, d). On histopathological examination,both regions were comprised of spindle cells (Figure 1e, f ).
The non-pigmented tumour however, showed no vascular
loops or lymphocytes, while the pigmented tumor did.
Both tumors were positive for HMB-45 and Melan-A
immunohistochemistry (Figure 2d). Cytological examination
of the non-pigmented tumour revealed no alterations
on chromosomes 3 or 8, while the pigmented tumour
contained monosomy 3 with alterations on chromosome
8 also.
Materials and methods
The entire eye was formalin fixed, paraffin embedded
(FFPE) and routinely processed and stained with hema-
toxylin-eosin (H&E). This tissue was obtained and managed
in accordance with the guidelines of the declaration of
Helsinki. Cytomorphology was assessed on H&E sections
and categorized according to the modified Callender system
Figure 2 Imaging and immunohistochemical findings. (a) T1 weighted MRI of the globe: an elevated intraocular lesion at the posterior pole
of moderately high signal. (b) B-scan ultrasound: dome shaped lesion at the posterior pole. (c) A-scan ultrasound: solid lesion at the posterior
pole with low internal reflectivity and a kappa angle. (d) Immunohistochemistry: HMB-45 positive staining.
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were used to confirm the diagnosis of uveal melanoma.
Vascular loops were assessed using the PAS reagent with-
out counterstaining. The presence of tumour infiltrating
lymphocytes was assessed using immunohistochemical
antibodies for B cells, L-26 (Dako) and T cells UCHL-1
(Dako). Significance was considered as more than 100
lymphocytes per 20 high-powered (43×) fields [7]. Fresh
tumour tissue was taken for single nucleotide polymorph-
ism analysis following enucleation, and further processed
to assess for chromosomal abnormalities. DNA extraction
from the samples was performed using commercially
available isolation kits (DNeasy Kit; Qiagen, Germantown,
MD) according to the manufacturer-suggested protocols.
A labeling and detecting whole-genome genotyping sample
kit (Illumina Human 660 W-Quad v1; Illumina San Diego,
CA) was used to analyze for monosomy 3. Data analysis
was performed using commercial data analysis software
(GenomeStudio with KaryoStudio module; Illumina).
Discussion
This case of uveal melanoma showed a lesion that under-
went rapid growth, enlarging and developing a ring of
pigmentation over a period of only 10 months. Furthermore,
the seemingly aggressive portion of the tumour correlated
with apparent transformation from a non-pigmented slow
growing normal heterodisomy 3 tumour to a pigmented
monosomy 3 tumor that also exhibited other poor prog-
nostic factors including the presence of vascular loops andtumour associated lymphocytes. This is similar to one
other case reported by Callejo et al. [8] in which an appar-
ently quiescent melanoma suddenly enlarged, became
necrotic, and apparently transformed from an indolent
disomy 3 spindle cell uveal melanoma to an aggressive
monosomy 3 epithelioid tumour. White et al. [9] also
reported a similar case in which the uveal melanoma
tumour showed grossly distinct pigmented and non-
pigmented regions. These two regions however, were
morphologically different, the pigmented area of the uveal
melanoma composed of small epitheliod cells while the
non pigmented area was comprised of large pleiomorphic
epitheliod cells. This morphological heterogeneity cor-
responded with cytogenetic heterogeneity, the two areas
showing different karyotypes, the pigmented tumor show-
ing monosomy 3, and the non-pigmented tumour showing
two normal chromosomes 3. DNA analysis of both pig-
mented and non-pigmented regions revealed loss of het-
erozygosity at all informative loci at chromosome 3,
suggesting that duplication of the monosomy 3 chromo-
some had occurred (isodisomy 3) and that the non pig-
mented tumour had evolved from the pigmented tumour.
Isodisomy 3 is thought to occur in 5-10% of cases of
uveal melanoma, and is prognostically equivalent to that
of monosomy 3 status [10]. It is associated with the high
risk class II expression signature and the development of
metastasis, implying that chromosome 3 in monosomy 3
tumours, is defective at one or more tumour suppressor
loci, this then being duplicated in isodisomy 3 tumours
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also been previously described in tumour specimens
[11-13], found to occur in 14-18% of uveal melanomas
[14]. Evidence of subclone formation from analyses of
harvested cells [2,9] and morphological heterogeneity
corresponding with cytogenetic heterogeneity has also
been reported by Sandinha et al. [11].
These cases suggest that monosomy 3 may arise at any
stage during tumour development. As a result, this raises
the question of whether small tumours and disomy 3 uveal
melanomas should be treated early to prevent progression
or evolution into a high grade lesion with more malignant
potential. Furthermore, these cases in which there is clearly
demonstrated intratumoral heterogeneity further emphasize
its previously reported existence [14,15]. The limitations
of prognostic fine needle biopsy are also highlighted; as
aspirate material may not adequately represent the tumor
in its entirety. Thus, the usefulness of this investigation as
a prognostic test, especially in the scenario of a negative
result for monosomy 3, may also need to be further
considered.
More recently, the gene expression profiling assay has
been shown to not be affected by intratumoral heterogen-
eity in a small sample of tumours [16], and in the recent
Collaborative Ocular Oncology Group study [17], has
been shown to be technically successful and to be the
most accurate prognostic marker compared with clinical
and histopathological factors, a class II signature more
strongly associated with metastasis than any other prog-
nostic factor including monosomy 3 [17]. However, it is
important to note that although a statistically significantly
small number of metastasis did occur in 3 patients (1.1%)
with class I tumours compared with 44 patients (25.9%)
with class II tumours at a median follow up of 17.4 months
(p < 0.0001), metastases still do arise from a small number
of class I tumours [17]. Therefore, errors relating to tissue
sampling bias, tumour progression, and the unpredictable
clinical behavior of uveal melanoma with delayed devel-
opment of metastases as a result of tumour dormancy,
support the need for longer term follow up data of the
molecular classification to further validate its accuracy
and reliability.Conclusion
We present an atypical peripapillary uveal melanoma that
demonstrated rapid growth and apparent transformation
into a monosomy 3 tumour, a case that challenges current
concepts of the pathogenesis of uveal melanoma, and
highlights intratumoural heterogeneity and sampling
error as persistent sources of uncertainty. Although gene
expression profiling appears to be unaffected by this,
further long-term study is needed to assess the accuracy
of this molecular classification.Competing interests
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